Kazuma Yamakawa

Summary

Publications

  1. pmc Electrical vagus nerve stimulation attenuates systemic inflammation and improves survival in a rat heatstroke model
    Kazuma Yamakawa
    Department of Traumatology and Acute Critical Medicine, Osaka University Graduate School of Medicine, Osaka, Japan
    PLoS ONE 8:e56728. 2013
  2. pmc Recombinant human soluble thrombomodulin in sepsis-induced disseminated intravascular coagulation: a multicenter propensity score analysis
    Kazuma Yamakawa
    Department of Traumatology and Acute Critical Medicine, Osaka University Graduate School of Medicine, 2 15, Yamadaoka, Suita, Osaka, 565 0871, Japan
    Intensive Care Med 39:644-52. 2013
  3. doi request reprint Platelet mitochondrial membrane potential correlates with severity in patients with systemic inflammatory response syndrome
    Kazuma Yamakawa
    Department of Traumatology and Acute Critical Medicine, Osaka University Graduate School of Medicine, Osaka, Japan
    J Trauma Acute Care Surg 74:411-7; discussion 418. 2013
  4. pmc A novel technique of differential lung ventilation in the critical care setting
    Kazuma Yamakawa
    Department of Traumatology and Acute Critical Medicine, Osaka University Graduate School of Medicine, 2 15 Yamadaoka Suita, Osaka 565 0871, Japan
    BMC Res Notes 4:134. 2011
  5. pmc Treatment effects of recombinant human soluble thrombomodulin in patients with severe sepsis: a historical control study
    Kazuma Yamakawa
    Department of Emergency and Critical Care, Osaka General Medical Center, 3 1 56 Bandai Higashi, Sumiyoshi ku, Osaka, Japan
    Crit Care 15:R123. 2011
  6. pmc Assessment of risk factors related to healthcare-associated methicillin-resistant Staphylococcus aureus infection at patient admission to an intensive care unit in Japan
    Kazuma Yamakawa
    Department of Emergency and Critical Care, Osaka General Medical Center, Osaka, Japan
    BMC Infect Dis 11:303. 2011
  7. doi request reprint Maximal chemiluminescent intensity in response to lipopolysaccharide assessed by endotoxin activity assay on admission day predicts mortality in patients with sepsis
    Takeyuki Kiguchi
    Department of Emergency and Critical Care, Osaka General Medical Center, Osaka, Japan
    Crit Care Med 41:1443-9. 2013
  8. doi request reprint Recombinant human soluble thrombomodulin improves mortality and respiratory dysfunction in patients with severe sepsis
    Yoshihito Ogawa
    Department of Emergency and Critical Care, Osaka General Medical Center, Osaka, Japan
    J Trauma Acute Care Surg 72:1150-7. 2012
  9. pmc Benefit profile of recombinant human soluble thrombomodulin in sepsis-induced disseminated intravascular coagulation: a multicenter propensity score analysis
    Jumpei Yoshimura
    Department of Emergency and Critical Care, Osaka General Medical Center, 3 1 56 Bandai Higashi, Sumiyoshi ku, Osaka, 558 8558, Japan
    Crit Care 19:78. 2015
  10. doi request reprint Systemic involvement of high-mobility group box 1 protein and therapeutic effect of anti-high-mobility group box 1 protein antibody in a rat model of crush injury
    Junya Shimazaki
    Department of Traumatology and Acute Critical Medicine, Osaka University Graduate School of Medicine, Osaka, Japan
    Shock 37:634-8. 2012

Collaborators

Detail Information

Publications14

  1. pmc Electrical vagus nerve stimulation attenuates systemic inflammation and improves survival in a rat heatstroke model
    Kazuma Yamakawa
    Department of Traumatology and Acute Critical Medicine, Osaka University Graduate School of Medicine, Osaka, Japan
    PLoS ONE 8:e56728. 2013
    ..These findings may provide a novel therapeutic strategy to combat severe heatstroke in the critical care setting...
  2. pmc Recombinant human soluble thrombomodulin in sepsis-induced disseminated intravascular coagulation: a multicenter propensity score analysis
    Kazuma Yamakawa
    Department of Traumatology and Acute Critical Medicine, Osaka University Graduate School of Medicine, 2 15, Yamadaoka, Suita, Osaka, 565 0871, Japan
    Intensive Care Med 39:644-52. 2013
    ..We hypothesized that patients with sepsis-induced DIC receiving treatment with rhTM would have improved mortality compared with those with similar acuity who did not...
  3. doi request reprint Platelet mitochondrial membrane potential correlates with severity in patients with systemic inflammatory response syndrome
    Kazuma Yamakawa
    Department of Traumatology and Acute Critical Medicine, Osaka University Graduate School of Medicine, Osaka, Japan
    J Trauma Acute Care Surg 74:411-7; discussion 418. 2013
    ..The objective of this study was to investigate mitochondrial membrane potential (ΔΨm) and apoptosis in circulating platelets in patients with systemic inflammatory response syndrome (SIRS)...
  4. pmc A novel technique of differential lung ventilation in the critical care setting
    Kazuma Yamakawa
    Department of Traumatology and Acute Critical Medicine, Osaka University Graduate School of Medicine, 2 15 Yamadaoka Suita, Osaka 565 0871, Japan
    BMC Res Notes 4:134. 2011
    ..abstract:..
  5. pmc Treatment effects of recombinant human soluble thrombomodulin in patients with severe sepsis: a historical control study
    Kazuma Yamakawa
    Department of Emergency and Critical Care, Osaka General Medical Center, 3 1 56 Bandai Higashi, Sumiyoshi ku, Osaka, Japan
    Crit Care 15:R123. 2011
    ..The purpose of this study was to examine the efficacy of rhTM for treating patients with sepsis-induced disseminated intravascular coagulation (DIC)...
  6. pmc Assessment of risk factors related to healthcare-associated methicillin-resistant Staphylococcus aureus infection at patient admission to an intensive care unit in Japan
    Kazuma Yamakawa
    Department of Emergency and Critical Care, Osaka General Medical Center, Osaka, Japan
    BMC Infect Dis 11:303. 2011
    ..Predicting HA-MRSA infection on admission can strengthen precautions against MRSA transmission. This study aimed to clarify the risk factors for HA-MRSA infection in an ICU from data obtained within 24 hours of patient ICU admission...
  7. doi request reprint Maximal chemiluminescent intensity in response to lipopolysaccharide assessed by endotoxin activity assay on admission day predicts mortality in patients with sepsis
    Takeyuki Kiguchi
    Department of Emergency and Critical Care, Osaka General Medical Center, Osaka, Japan
    Crit Care Med 41:1443-9. 2013
    ....
  8. doi request reprint Recombinant human soluble thrombomodulin improves mortality and respiratory dysfunction in patients with severe sepsis
    Yoshihito Ogawa
    Department of Emergency and Critical Care, Osaka General Medical Center, Osaka, Japan
    J Trauma Acute Care Surg 72:1150-7. 2012
    ....
  9. pmc Benefit profile of recombinant human soluble thrombomodulin in sepsis-induced disseminated intravascular coagulation: a multicenter propensity score analysis
    Jumpei Yoshimura
    Department of Emergency and Critical Care, Osaka General Medical Center, 3 1 56 Bandai Higashi, Sumiyoshi ku, Osaka, 558 8558, Japan
    Crit Care 19:78. 2015
    ....
  10. doi request reprint Systemic involvement of high-mobility group box 1 protein and therapeutic effect of anti-high-mobility group box 1 protein antibody in a rat model of crush injury
    Junya Shimazaki
    Department of Traumatology and Acute Critical Medicine, Osaka University Graduate School of Medicine, Osaka, Japan
    Shock 37:634-8. 2012
    ..Thus, HMGB1 appears to be a therapeutic target, and anti-HMGB1 antibody may become a promising novel therapy against crush injury to prevent the progression to multiple organ failure...
  11. doi request reprint Benefit profile of recombinant human soluble thrombomodulin in sepsis-induced disseminated intravascular coagulation: a multicenter propensity score analysis
    Jumpei Yoshimura
    Department of Emergency and Critical Care, Osaka General Medical Center, 3 1 56 Bandai Higashi, Sumiyoshi ku, Osaka, 558 8558, Japan
    Crit Care 19:810. 2015
    ....
  12. doi request reprint The clinical significance of circulating soluble RAGE in patients with severe sepsis
    Hisatake Matsumoto
    From the Departments of Traumatology and Acute Critical Medicine H M, N M, H O, J S, K Y, T S, and Clinical Epidemiology and Biostatistics K Y, Osaka University Graduate School of Medicine, Osaka, Japan
    J Trauma Acute Care Surg 78:1086-93; discussion 1093-4. 2015
    ..However, the significance of the soluble isoform of RAGE (sRAGE) has not been clarified in critical illness. We investigated circulating sRAGE in blood samples from septic patients...
  13. pmc Enhanced expression of cell-specific surface antigens on endothelial microparticles in sepsis-induced disseminated intravascular coagulation
    Hisatake Matsumoto
    Department of Traumatology and Acute Critical Medicine, Osaka University Graduate School of Medicine and Laboratory for Clinical Investigation, Osaka University Hospital, Osaka, Japan
    Shock 43:443-9. 2015
    ....
  14. pmc First clinical experience with IVR-CT system in the emergency room: Positive impact on trauma workflow
    Daiki Wada
    Department of Emergency and Critical Care, Osaka General Medical Center, 3 1 56 Bandai Higashi, Sumiyoshi ku, Osaka, 558 8558, Japan
    Scand J Trauma Resusc Emerg Med 20:52. 2012
    ..Our new workflow concept, which provides faster time to definitive intervention, appears to be effective...